Elsa: The FDA’s Artificial Intelligence Agent
The U.S. Food and Drug Administration (FDA) launched its first agency-level generative AI assistant, Elsa, in June 2025. Aimed at all 18,000 employees (scientific reviewers, compliance investigators, policymakers, etc.), this tool marks a significant step in the FDA’s digital transformation, aiming to enhance review efficiency, reduce repetitive paperwork, and accelerate the review process for drugs … Read more